Get the Stockscreener App
12.64
3.22%
-0.42
After Hours:
12.64
10 X Genomics Inc stock is traded at $12.64, with a volume of 2.52M.
It is down -3.22% in the last 24 hours and down -1.33% over the past month.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$13.06
Open:
$13
24h Volume:
2.52M
Relative Volume:
0.76
Market Cap:
$1.45B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-6.2574
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-9.46%
1M Performance:
-1.33%
6M Performance:
+16.50%
1Y Performance:
-43.95%
1-Day Range:
$12.54
$13.01
1-Week Range:
$12.38
$14.08
52-Week Range:
$6.78
$24.38
10 X Genomics Inc Stock (TXG) Company Profile
Name
10 X Genomics Inc
Sector
Industry
Phone
(925) 401-7300
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
12.64 | 1.57B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-22-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-18-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-10-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-25-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-03-24 | Resumed | Jefferies | Hold |
| May-01-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-10-23 | Initiated | Barclays | Overweight |
| Mar-31-23 | Initiated | Stephens | Overweight |
| Feb-02-23 | Initiated | UBS | Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Aug-18-22 | Downgrade | Goldman | Neutral → Sell |
| Jul-25-22 | Initiated | Canaccord Genuity | Buy |
| Jul-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-15-21 | Initiated | William Blair | Outperform |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Jul-10-20 | Initiated | Stifel | Buy |
| Mar-05-20 | Initiated | Guggenheim | Buy |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-07-19 | Initiated | BofA/Merrill | Buy |
| Oct-07-19 | Initiated | Cowen | Outperform |
| Oct-07-19 | Initiated | JP Morgan | Overweight |
| Sep-24-19 | Initiated | Evercore ISI | Outperform |
View All
10 X Genomics Inc Stock (TXG) Latest News
Can trapped investors hope for a rebound in 10x Genomics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser
10x Genomics $TXG Shares Bought by Voleon Capital Management LP - MarketBeat
10x Genomics $TXG Shares Purchased by Amundi - Defense World
10x Genomics (NASDAQ:TXG) Now Covered by Analysts at Piper Sandler - Defense World
10x Genomics (TXG) Stock Is Up, What You Need To Know - Yahoo Finance
Piper Sandler Initiates 10x Genomics at Neutral With $15 Price Target - MarketScreener
Piper Sandler initiates 10X Genomics stock coverage with Neutral rating - Investing.com
Millennium Management LLC Acquires 4,371,327 Shares of 10x Genomics $TXG - MarketBeat
Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know - Yahoo Finance
Transcript : 10x Genomics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 11 - MarketScreener
Jacobs Levy Equity Management Inc. Buys 1,135,356 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics and Cliseq Ltd. to investigate single cell applications - MSN
346,794 Shares in 10x Genomics $TXG Purchased by Caxton Associates LLP - MarketBeat
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics - BioSpace
Cliseq Ltd., 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics - MarketScreener
1,500 Patients Worldwide: 10x Genomics' Groundbreaking Study Could End Painful Bone Marrow Tests - Stock Titan
Custom Dashboard Highlights 10x Genomics Inc. Price Momentum2025 Key Lessons & Long-Term Safe Investment Ideas - beatles.ru
Quant Funds Rotate Into 10x Genomics Inc. Stock2025 Market Sentiment & Capital Efficient Trading Techniques - beatles.ru
Perbak Capital Partners LLP Purchases Shares of 35,044 10x Genomics $TXG - MarketBeat
What are the future prospects of 10x Genomics Inc.Quarterly Risk Review & Fast Entry and Exit Trade Plans - 강소기업뉴스
10x Genomics (NASDAQ:TXG) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
RA Capital Management L.P. Has $16.97 Million Stock Position in 10x Genomics $TXG - MarketBeat
Visual analytics tools that track 10x Genomics Inc. performanceEarnings Beat & Risk Managed Investment Entry Signals - Newser
PDT Partners LLC Grows Position in 10x Genomics $TXG - MarketBeat
Can 10x Genomics Inc. be the next market leaderEarnings Overview Report & Daily Stock Trend Watchlist - 더경남뉴스
Can 10x Genomics Inc. stock double in the next yearBull Run & Breakout Confirmation Alerts - خودرو بانک
Is 10x Genomics Inc. a potential multi baggerPortfolio Gains Summary & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Is 10x Genomics Inc. stock a good pick for beginnersWeekly Trade Analysis & Low Volatility Stock Suggestions - خودرو بانک
Is 10x Genomics Inc. stock a buy or sellJuly 2025 Earnings & Accurate Buy Signal Alerts - خودرو بانک
Using economic indicators to assess 10x Genomics Inc. potentialJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Scale Biosciences Acquired by 10x Genomics - San Diego Business Journal
Volume spikes in 10x Genomics Inc. stock – what they meanJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Can swing trading help recover from 10x Genomics Inc. lossesJuly 2025 Opening Moves & Safe Entry Point Alerts - Newser
Real time alert setup for 10x Genomics Inc. performanceJuly 2025 Opening Moves & Reliable Trade Execution Plans - Newser
Technical signs of recovery in 10x Genomics Inc.July 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Analyzing drawdowns of 10x Genomics Inc. with statistical toolsWeekly Trade Review & Daily Oversold Stock Bounce Ideas - Newser
What MACD signals say about 10x Genomics Inc.Inflation Watch & Fast Entry Momentum Alerts - Newser
Hsbc Holdings PLC Sells 21,746 Shares of 10x Genomics $TXG - MarketBeat
Should you hold or exit 10x Genomics Inc. nowWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is 10x Genomics Inc. in a long term uptrendJuly 2025 Price Swings & Safe Capital Investment Plans - خودرو بانک
Can 10x Genomics Inc. grow without external funding2025 Buyback Activity & Free Fast Gain Swing Trade Alerts - خودرو بانک
Is 10x Genomics Inc. stock influenced by commodity pricesWatch List & Community Consensus Picks - خودرو بانک
Is this a good reentry point in 10x Genomics Inc.Quarterly Performance Summary & Target Return Focused Stock Picks - Newser
Russell Investments Group Ltd. Has $713,000 Stake in 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. still worth holding after the dip2025 Year in Review & Free Community Consensus Stock Picks - Newser
Does 10x Genomics Inc. meet Warren Buffett’s criteriaTrade Signal Summary & Short-Term High Return Ideas - خودرو بانک
Detecting price anomalies in 10x Genomics Inc. with AIJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - Newser
Technical analysis overview for 10x Genomics Inc. stockJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Chart based analysis of 10x Genomics Inc. trends2025 Retail Activity & Safe Entry Zone Identification - Newser
Applying big data sentiment scoring on 10x Genomics Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - Newser
What the charts say about 10x Genomics Inc. todayJuly 2025 Patterns & Verified Technical Signals - Newser
10 X Genomics Inc Stock (TXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.30%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):